Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 455

1.

Functional screening identifies miRNAs influencing apoptosis and proliferation in colorectal cancer.

Christensen LL, Holm A, Rantala J, Kallioniemi O, Rasmussen MH, Ostenfeld MS, Dagnaes-Hansen F, Øster B, Schepeler T, Tobiasen H, Thorsen K, Sieber OM, Gibbs P, Lamy P, Hansen TF, Jakobsen A, Riising EM, Helin K, Lubinski J, Hagemann-Madsen R, Laurberg S, Ørntoft TF, Andersen CL.

PLoS One. 2014 Jun 3;9(6):e96767. doi: 10.1371/journal.pone.0096767. eCollection 2014.

PMID:
24892549
[PubMed - in process]
Free PMC Article
2.

Mutational context and diverse clonal development in early and late bladder cancer.

Nordentoft I, Lamy P, Birkenkamp-Demtröder K, Shumansky K, Vang S, Hornshøj H, Juul M, Villesen P, Hedegaard J, Roth A, Thorsen K, Høyer S, Borre M, Reinert T, Fristrup N, Dyrskjøt L, Shah S, Pedersen JS, Ørntoft TF.

Cell Rep. 2014 Jun 12;7(5):1649-63. doi: 10.1016/j.celrep.2014.04.038. Epub 2014 May 15.

PMID:
24835989
[PubMed - in process]
Free Article
3.

Iron homeostasis and anemia markers in early breast cancer.

Lamy PJ, Durigova A, Jacot W.

Clin Chim Acta. 2014 Jul 1;434:34-40. doi: 10.1016/j.cca.2014.04.011. Epub 2014 Apr 24.

PMID:
24768787
[PubMed - in process]
4.

Clinical validation of the detection of KRAS and BRAF mutations from circulating tumor DNA.

Thierry AR, Mouliere F, El Messaoudi S, Mollevi C, Lopez-Crapez E, Rolet F, Gillet B, Gongora C, Dechelotte P, Robert B, Del Rio M, Lamy PJ, Bibeau F, Nouaille M, Loriot V, Jarrousse AS, Molina F, Mathonnet M, Pezet D, Ychou M.

Nat Med. 2014 Apr;20(4):430-5. doi: 10.1038/nm.3511. Epub 2014 Mar 23.

PMID:
24658074
[PubMed - indexed for MEDLINE]
5.

Epidemiological study of prostate cancer (EPICAP): a population-based case-control study in France.

Menegaux F, Anger A, Randrianasolo H, Mulot C, Laurent-Puig P, Iborra F, Bringer JP, Leizour B, Thuret R, Lamy PJ, Rébillard X, Trétarre B; EPICAP Study Group.

BMC Cancer. 2014 Feb 19;14:106. doi: 10.1186/1471-2407-14-106.

PMID:
24552491
[PubMed - in process]
Free PMC Article
6.

Prognostic impact of the inclusion of uPA/PAI-1 tumor levels in the current adjuvant treatment decision-making for early breast cancer.

Saadoun H, Lamy PJ, Thezenas S, Pouderoux S, Bibeau F, Montels F, Romieu G, Colombo PE, Gutowski M, Jacot W.

Future Oncol. 2014 Feb;10(2):195-209. doi: 10.2217/fon.13.177.

PMID:
24490606
[PubMed - in process]
7.

BRCA1 promoter hypermethylation, 53BP1 protein expression and PARP-1 activity as biomarkers of DNA repair deficit in breast cancer.

Jacot W, Thezenas S, Senal R, Viglianti C, Laberenne AC, Lopez-Crapez E, Bibeau F, Bleuse JP, Romieu G, Lamy PJ.

BMC Cancer. 2013 Nov 5;13:523. doi: 10.1186/1471-2407-13-523.

PMID:
24191908
[PubMed - indexed for MEDLINE]
Free Article
8.

[Evaluation of (-2)proPSA in combination with total PSA and free PSA for the early detection of prostate cancer].

Lamy PJ, Montels F, Tosi D, Leizour B, Bascoul-Mollevi C, Castan F, Roques S, Nielloud F, Rebillard X.

Ann Biol Clin (Paris). 2013 Sep-Oct;71(5):537-44. doi: 10.1684/abc.2013.0894. French.

PMID:
24113439
[PubMed - indexed for MEDLINE]
9.

[Vitamin D and breast cancer: physiopathology, biological and clinical implications].

Firmin N, Lamy PJ, Romieu G, Jacot W.

Bull Cancer. 2014 Mar;101(3):266-82. doi: 10.1684/bdc.2013.1826. Review. French.

PMID:
24103818
[PubMed - indexed for MEDLINE]
10.

Cathepsin D stimulates the activities of secreted plasminogen activators in the breast cancer acidic environment.

Maynadier M, Farnoud R, Lamy PJ, Laurent-Matha V, Garcia M, Rochefort H.

Int J Oncol. 2013 Nov;43(5):1683-90. doi: 10.3892/ijo.2013.2095. Epub 2013 Sep 10.

PMID:
24026424
[PubMed - indexed for MEDLINE]
11.

DNA methylation signatures for prediction of biochemical recurrence after radical prostatectomy of clinically localized prostate cancer.

Haldrup C, Mundbjerg K, Vestergaard EM, Lamy P, Wild P, Schulz WA, Arsov C, Visakorpi T, Borre M, Høyer S, Orntoft TF, Sørensen KD.

J Clin Oncol. 2013 Sep 10;31(26):3250-8. doi: 10.1200/JCO.2012.47.1847. Epub 2013 Aug 5.

PMID:
23918943
[PubMed - indexed for MEDLINE]
12.

SISH/CISH or qPCR as alternative techniques to FISH for determination of HER2 amplification status on breast tumors core needle biopsies: a multicenter experience based on 840 cases.

Jacquemier J, Spyratos F, Esterni B, Mozziconacci MJ, Antoine M, Arnould L, Lizard S, Bertheau P, Lehmann-Che J, Fournier CB, Krieger S, Bibeau F, Lamy PJ, Chenard MP, Legrain M, Guinebretière JM, Loussouarn D, Macgrogan G, Hostein I, Mathieu MC, Lacroix L, Valent A, Robin YM, Revillion F, Triki ML, Seaume A, Salomon AV, de Cremoux P, Portefaix G, Xerri L, Vacher S, Bièche I, Penault-Llorca F.

BMC Cancer. 2013 Jul 22;13:351. doi: 10.1186/1471-2407-13-351.

PMID:
23875536
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Anemia and iron biomarkers in patients with early breast cancer. Diagnostic value of hepcidin and soluble transferrin receptor quantification.

Durigova A, Lamy PJ, Thezenas S, Pouderoux S, Montels F, Romieu G, Gutowski M, Jacot W.

Clin Chem Lab Med. 2013 Sep;51(9):1833-41. doi: 10.1515/cclm-2013-0031.

PMID:
23787470
[PubMed - indexed for MEDLINE]
14.

Circulating Cell-Free DNA from Colorectal Cancer Patients May Reveal High KRAS or BRAF Mutation Load.

Mouliere F, El Messaoudi S, Gongora C, Guedj AS, Robert B, Del Rio M, Molina F, Lamy PJ, Lopez-Crapez E, Mathonnet M, Ychou M, Pezet D, Thierry AR.

Transl Oncol. 2013 Jun 1;6(3):319-28. Print 2013 Jun.

PMID:
23730412
[PubMed]
Free PMC Article
15.

The HER2 amplicon in breast cancer: Topoisomerase IIA and beyond.

Jacot W, Fiche M, Zaman K, Wolfer A, Lamy PJ.

Biochim Biophys Acta. 2013 Aug;1836(1):146-57. doi: 10.1016/j.bbcan.2013.04.004. Epub 2013 Apr 26. Review.

PMID:
23628726
[PubMed - indexed for MEDLINE]
Free Article
16.

MiRNA-362-3p induces cell cycle arrest through targeting of E2F1, USF2 and PTPN1 and is associated with recurrence of colorectal cancer.

Christensen LL, Tobiasen H, Holm A, Schepeler T, Ostenfeld MS, Thorsen K, Rasmussen MH, Birkenkamp-Demtroeder K, Sieber OM, Gibbs P, Lubinski J, Lamy P; COLOFOL steering group, Laurberg S, Oster B, Hansen KQ, Hagemann-Madsen R, Byskov K, Ørntoft TF, Andersen CL.

Int J Cancer. 2013 Jul;133(1):67-78. doi: 10.1002/ijc.28010. Epub 2013 Feb 12.

PMID:
23280316
[PubMed - indexed for MEDLINE]
17.

Re: clinical validity/utility, change in practice patterns, and economic implications of risk stratifiers to predict outcomes for early-stage breast cancer: a systematic review.

Lamy PJ, Martin PM, Romieu G, Jacot W.

J Natl Cancer Inst. 2013 Jan 16;105(2):149. doi: 10.1093/jnci/djs492. Epub 2012 Dec 14. No abstract available.

PMID:
23243205
[PubMed - indexed for MEDLINE]
Free Article
18.

Non-CpG island promoter hypomethylation and miR-149 regulate the expression of SRPX2 in colorectal cancer.

Øster B, Linnet L, Christensen LL, Thorsen K, Ongen H, Dermitzakis ET, Sandoval J, Moran S, Esteller M, Hansen TF, Lamy P; COLOFOL steering group, Laurberg S, Ørntoft TF, Andersen CL.

Int J Cancer. 2013 May 15;132(10):2303-15. doi: 10.1002/ijc.27921. Epub 2012 Nov 21.

PMID:
23115050
[PubMed - indexed for MEDLINE]
19.

A high resolution genomic portrait of bladder cancer: correlation between genomic aberrations and the DNA damage response.

Schepeler T, Lamy P, Hvidberg V, Laurberg JR, Fristrup N, Reinert T, Bartkova J, Tropia L, Bartek J, Halazonetis TD, Pan CC, Borre M, Dyrskjøt L, Orntoft TF.

Oncogene. 2013 Aug 1;32(31):3577-86. doi: 10.1038/onc.2012.381. Epub 2012 Aug 27.

PMID:
22926521
[PubMed - indexed for MEDLINE]
20.

Identification and validation of new autoantibodies for the diagnosis of DCIS and node negative early-stage breast cancers.

Lacombe J, Mangé A, Jarlier M, Bascoul-Mollevi C, Rouanet P, Lamy PJ, Maudelonde T, Solassol J.

Int J Cancer. 2013 Mar 1;132(5):1105-13. doi: 10.1002/ijc.27766. Epub 2012 Aug 28.

PMID:
22886747
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk